leantaas.comHealthcare / Healthcare softwareFounded: 2010Funding to Date: $214.7MM
LeanTaaS is a developer of software designed to increase patient access to medical care by optimizing how health systems use expensive, constrained resources like infusion chairs, operating rooms, and inpatient beds.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/10/2020 | Series D | $20MM | $xx.xx | $491.79MM | Goldman Sachs, Insight Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,594,840
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Goldman Sachs, Insight Venture Partners
|
||||||
12/10/2020 | Series D-2 | $99.66MM | $xx.xx | $491.79MM | Goldman Sachs, Insight Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
7,831,935
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Goldman Sachs, Insight Venture Partners
|
||||||
12/12/2019 | Series C-3 | $45MM | $xx.xx | $345.39MM | Goldman Sachs | |
Price per Share
$xx.xx
Shares Outstanding
3,659,457
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Goldman Sachs
|
||||||
06/07/2019 | Series C-2 | $16MM | $xx.xx | $204.49MM | Insight Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,561,371
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Insight Venture Partners
|
||||||
11/13/2018 | Series C | $15MM | $xx.xx | $122.14MM | Insight Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,024,592
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Insight Venture Partners
|
||||||
11/14/2017 | Series B | $205,993.00 | $xx.xx | $73.07MM | Insight Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
160,318
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Insight Venture Partners
|
||||||
11/14/2017 | Series B-2 | $3.6MM | $xx.xx | $73.07MM | Insight Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,457,153
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Insight Venture Partners
|
||||||
11/14/2017 | Series B-3 | $15MM | $xx.xx | $73.07MM | Insight Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
3,163,622
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Insight Venture Partners
|
||||||
12/31/2010 | Series A | $229,766.00 | $xx.xx | $919,065.00 | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
612,710
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|